Status:
ACTIVE_NOT_RECRUITING
Art Therapy in Progressive Supranuclear Palsy
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
CurePSP
Conditions:
Progressive Supranuclear Palsy
Eligibility:
All Genders
Phase:
NA
Brief Summary
Our aim is to study the effect of art therapy for people with PSP, with a focus on alleviating the symptoms associated with PSP, enhancing the overall quality of life for patients, and reducing caregi...
Detailed Description
Progressive Supranuclear Palsy (PSP) is typically manifested by a multitude of distressing symptoms, including bradyphrenia and bradykinesia, speech dyspraxia, visual problems, and postural instabilit...
Eligibility Criteria
Inclusion
- Diagnosis of progressive supranuclear palsy
- Have the cognitive ability to provide informed consent
Exclusion
- Primary neurological diagnosis other than progressive supranuclear palsy
- Cognition too impaired to provide informed consent
Key Trial Info
Start Date :
January 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 2 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06588673
Start Date
January 14 2025
End Date
December 2 2026
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232